Skip to main content
OpenTrials
Completed

NCT Number: NCT00104156

Qigong Therapy for Individuals With Knee Osteoarthritis

The purpose of this study is to evaluate the effectiveness of Qigong therapy, an ancient Chinese practice, for pain relief and symptom improvement in people with knee osteoarthritis (OA).

Study hypotheses: 1) Qigong therapy will result in greater reduction of pain and greater symptom improvement than sham treatment. 2) Individuals with a history of complementary and alternative medicine (CAM) use will be more likely to experience benefits of Qigong therapy than those without such experience.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–80 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 2

Primary location

University of Medicine and Dentistry, New Jersey-Robert Wood Johnson Medical School, Newark, New Jersey, United States

Loading trial locations.

About this study

OA is the leading cause of disability in the United States. Standard treatment for OA is drug therapy; however, cost, side effects, and varying levels of effectiveness warrant the need for development of new treatments. Qigong therapy, which involves deep meditation, breathing exercises, and the harnessing of energy, may be an effective treatment for OA.

According to traditional Chinese medicine, Qi (Chi) is the "life force" that flows through the body and keeps people healthy and vital. In the practice of traditional Chinese medicine, arthritis is thought to be due to a blockage of the flow of Qi or a buildup of abnormal or damaging Qi. It is believed that releasing this buildup or breaking the blockage of Qi through Qigong therapy may relieve OA symptoms.

Participants will be randomly assigned to receive five sessions of either Qigong therapy or sham treatment over a period of 2 weeks. During Qigong therapy, a therapist will send his or her Qi to the arthritic knees through touch and meditation. Similar body work will be performed during the sham treatment, but no Qi will be harnessed. Self-report scales that measure pain, stiffness, anxiety, daily drug use, CAM use, and overall functioning will be used to assess participants. The assessments will occur at study start and at a 3-month follow-up visit.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Diagnosis of osteoarthritis at least 6 months prior to study entry
  • Able to understand English

Exclusion criteria

  • Inflammatory joint disease affecting leg movement
  • Knee replacement surgery on the OA knee
  • Depo-corticosteroid knee injections within 3 months prior to study entry
  • Pain in hips or lower back affecting leg movement
  • New arthritis drugs or other painkillers within 2 weeks prior to study entry
  • Investigational drugs within 30 days prior to study entry
  • Asthma requiring oral corticosteroids within 4 weeks prior to study entry

Treatment and study plan

External Qigong therapy

Procedure

Primary outcomes

  1. Pain, stiffness, and physical function scale results

Secondary outcomes

  1. McGill Pain Questionnaire (MPQ-SF) results

  2. Spielberger State-Trait Anxiety Scale (STAI) results

  3. Daily dosage of drugs for pain relief

  4. Range of motion for knees

  5. Time to walk 50 feet

Sponsors and collaborators

Lead sponsor

National Center for Complementary and Integrative Health (NCCIH)

Nih

Registry information

Official study title

Qigong Therapy for Osteoarthritis at Knees

Important dates

Study start
2005
Primary completion
2007
Study completion
2007
First posted
Feb 24, 2005
Registry last updated
Jan 25, 2008

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.